Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Merkel cell carcinoma in Israel

B Brenner1, A Katz, E Rakowski

  • 1Institute of Oncology, Rabin Medical Center, Petah Tikva, Israel.

Israel Journal of Medical Sciences
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel retro-inverso gonadotropin-releasing hormone (GnRH) immunogen elicits antibodies that neutralize the activity of native GnRH.

Endocrinology·2003
Same author

Noninvasive native fluorescence imaging of head and neck tumors.

Technology in cancer research & treatment·2003
Same author

Variation in the DCP1 gene, encoding the angiotensin converting enzyme ACE, is not associated with increased susceptibility to Alzheimer's disease.

Psychiatric genetics·2003
Same author

Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells.

Prostate cancer and prostatic diseases·2002
Same author

Interpretation of spring recession curves.

Ground water·2002
Same author

Ideal vitamin C intake.

BioFactors (Oxford, England)·2002

Merkel cell carcinoma, a rare skin cancer, was studied in Israel. Findings show it affects older adults, typically on sun-exposed skin, with a 58% 3-year survival rate.

Area of Science:

  • Oncology
  • Dermatology
  • Epidemiology

Background:

  • Merkel cell carcinoma (MCC) is a rare, highly malignant skin cancer.
  • Limited data exists on MCC's clinical and epidemiologic characteristics in Israel.

Purpose of the Study:

  • To report the first clinical and epidemiologic characteristics of Merkel cell carcinoma in Israel.
  • To compare findings with international data and identify unique population-specific features.

Main Methods:

  • Retrospective analysis of Merkel cell carcinoma cases in Israel.
  • Collection of data on patient demographics, disease characteristics, and outcomes.

Main Results:

  • Average age at diagnosis was 69 years, with equal sex distribution.

Related Experiment Videos

  • MCC predominantly occurred on sun-exposed skin, with a 3-year survival rate of 58%.
  • Unique findings included a predominance of Ashkenazic Jews and a high rate of second malignancies.

    • Conclusions:

    • Findings are largely consistent with international MCC data.
    • Predominance in Ashkenazic Jews and increased second malignancy rates are notable.
    • Increased awareness of this aggressive skin cancer in Israel is crucial.